Prosecution Insights
Last updated: October 02, 2026
Application No. 17/598,034

EXPLOSIVE COMPOSITION AND METHOD FOR MANUFACTURING SAME, AND METHOD FOR MANUFACTURING HETEROATOM-DOPED NANODIAMOND

Non-Final OA §102§103
Filed
Sep 24, 2021
Priority
Mar 26, 2019 — JP 2019-058397 +2 more
Examiner
FELTON, AILEEN BAKER
Art Unit
1734
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Daicel Corporation
OA Round
4 (Non-Final)
52%
Grant Probability
Moderate
4-5
OA Rounds
0m
Est. Remaining
68%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allowance Rate
233 granted / 449 resolved
-13.1% vs TC avg
Strong +16% interview lift
Without
With
+16.5%
Interview Lift
resolved cases with interview
Typical timeline
4y 5m
Avg Prosecution
51 currently pending
Career history
497
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
64.8%
+24.8% vs TC avg
§102
15.8%
-24.2% vs TC avg
§112
17.0%
-23.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 449 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 2, 9-11, 13, 15, and 16 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Chan (5750921). Regarding claims 1, 2, 9-11, 13, 15, and 16, Chan discloses a mixture of 95 % HMX with 5 % of vinylidene fluoride and hexafluoroproylene copolymer (meets organic heteroatom and contains F). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 5 is rejected under 35 U.S.C. 103 as being unpatentable over Chan as applied above and further in view of Deisenroth (4405534). Regarding claim 5, Deisenroth teaches a plastic bonded explosive including RDX of size 60 µm (ex. 1). It would have been obvious to one having ordinary skill in the art at the time the invention was made and/or filed to use the particle size of RDX as taught by the prior art with the invention of Chan since both relate to similar plastic bonded explosives that include RDX and since the prior art suggests that it is known to use RDX with that particle size and a plastic bonded explosive. Claim 14 is rejected under 35 U.S.C. 103 as being unpatentable over Chan as applied above and further in view of JP 3787848. JP 3787848 discloses propellant that includes a binder such as silane at 10 % and an explosive such as RDX or HMX at 90 % (0021, 0024, and 0026). It would have been obvious to one having ordinary skill in the art at the time the invention was made and/or filed to use the binder as taught by JP 3787848 with the composition of Chan since both explosives contain high amounts of nitramine explosive with a binder. One of skill in the art would have an expectation of success to replace one known binder for another. Response to Arguments Applicant's arguments have been considered but are moot in view of the new ground(s) of rejection. Allowable Subject Matter Claim 12 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to AILEEN BAKER FELTON whose telephone number is (571)272-6875. The examiner can normally be reached Monday 9-5:30, Thursday 11-3, Friday 9-5:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jonathan Johnson can be reached on 571-272-1177. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AILEEN B FELTON/Primary Examiner, Art Unit 1734
Read full office action

Prosecution Timeline

Show 7 earlier events
Sep 03, 2025
Response after Non-Final Action
Sep 05, 2025
Response after Non-Final Action
Nov 13, 2025
Non-Final Rejection mailed — §102, §103
Feb 10, 2026
Applicant Interview (Telephonic)
Feb 19, 2026
Examiner Interview Summary
Mar 13, 2026
Response Filed
Jun 10, 2026
Final Rejection mailed — §102, §103
Sep 09, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12735368
Thruster Propellants
3y 9m to grant Granted Sep 15, 2026
Patent 12723009
PROPELLANT CHARGE
1y 9m to grant Granted Sep 01, 2026
Patent 12715821
METAL HYDRIDE NANOPARTICLES
2y 5m to grant Granted Aug 25, 2026
Patent 12709586
SYSTEMS AND METHODS FOR CONTROLLABLE SYNTHESIS OF ENERGETIC NANOCOMPOSITES
1y 12m to grant Granted Aug 18, 2026
Patent 12692208
REDUCED VAPOR-TOXICITY HYDRAZINE COMPOSITION
5y 1m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

4-5
Expected OA Rounds
52%
Grant Probability
68%
With Interview (+16.5%)
4y 5m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 449 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month